Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pamatolol

Known as: (2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester, methyl (4-(2-hydroxy-3-(isopropylamino)propoxy)phenylethyl)carbamate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe metabolism of pamatolol was studied in man, dogs, rats and mice after oral administration of a single dose. The drug… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1985
1985
SummaryThe effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1982
1982
Hamster adipocyte beta-adrenergic receptors were characterized by the effect on the lipolysis rate of several selective beta… Expand
Is this relevant?
1982
1982
SummaryPrenalterol, previously characterized as a functionally cardioselective partial β-adrenoceptor agonist, was shown to relax… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1982
1982
Prenalterol, previously characterized as a functionally cardioselective partial beta-adrenoceptor agonist, was shown to relax K… Expand
Is this relevant?
1981
1981
The effects of a nonselective (isoproterenol), a beta-1 selective (prenalterol) and a beta-2-selective (procaterol) agonist on… Expand
Is this relevant?
1979
1979
  • B. Johansson
  • Journal of cardiovascular pharmacology
  • 1979
  • Corpus ID: 10010513
Three beta-adrenoceptor antagonists--atenolol (A), metoprolol (M), and pamatolol (P)--were examined with respect to their effects… Expand
Is this relevant?
1979
1979
The systemic bioavailability, elimination half-life (t1/2), and plasma concentration--response relationships of pamatolol, a… Expand
Is this relevant?
1979
1979
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol 
Is this relevant?
1978
1978
A Phase I evaluation of a new adrenoceptor blocker, pamatolol, was performed in 10 healthy male volunteers. Minor reductions in… Expand
Is this relevant?